Peptide compounds for treating obesity and insulin resistance

Details Peptide compounds for treating obesity and insulin resistance Peptide compounds for treating obesity and insulin resistance

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61P 3/00 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2702442

Compounds comprising an angiopoietin-like protein 6 (Angpt16) peptide for use in the treatment of metabolic syndrome, in particular, obesity and insulin resistance are described.

L'invention concerne des composés qui comprennent un peptide protéine 6 de type angiopoïétine (Angptl6), destinés à une utilisation pour le traitement du syndrome métabolique, notamment de l'obésité et de la résistance à l'insuline.

Affiliated with

Also associated with

Rating

Peptide compounds for treating obesity and insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide compounds for treating obesity and insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide compounds for treating obesity and insulin resistance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1898715